{"nct_id":"NCT03350451","title":"An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1","status":"COMPLETED","status_verified_date":"2024-03","start_date":"2018-04-04","start_date_type":"ACTUAL","primary_completion_date":"2023-02-07","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ALNY"]}